| Literature DB >> 28496441 |
André Alex Grassmann1, Frederico Schmitt Kremer1, Júlia Cougo Dos Santos1, Jéssica Dias Souza1, Luciano da Silva Pinto1, Alan John Alexander McBride1,2.
Abstract
Leptospira spp. are diderm (two membranes) bacteria that infect mammals causing leptospirosis, a public health problem with global implications. Thousands of people die every year due to leptospirosis, especially in developing countries with tropical climates. Prophylaxis is difficult due to multiple factors, including the large number of asymptomatic hosts that transmit the bacteria, poor sanitation, increasing numbers of slum dwellers, and the lack of an effective vaccine. Several leptospiral recombinant antigens were evaluated as a replacement for the inactivated (bacterin) vaccine; however, success has been limited. A prospective vaccine candidate is likely to be a surface-related protein that can stimulate the host immune response to clear leptospires from blood and organs. In this study, a comprehensive bioinformatics approach based on reverse and structural vaccinology was applied toward the discovery of novel leptospiral vaccine candidates. The Leptospira interrogans serovar Copenhageni strain L1-130 genome was mined in silico for the enhanced identification of conserved β-barrel (βb) transmembrane proteins and outer membrane (OM) lipoproteins. Orthologs of the prospective vaccine candidates were screened in the genomes of 20 additional Leptospira spp. Three-dimensional structural models, with a high degree of confidence, were created for each of the surface-exposed proteins. Major histocompatibility complex II (MHC-II) epitopes were identified, and their locations were mapped on the structural models. A total of 18 βb transmembrane proteins and 8 OM lipoproteins were identified. These proteins were conserved among the pathogenic Leptospira spp. and were predicted to have epitopes for several variants of MHC-II receptors. A structural and functional analysis of the sequence of these surface proteins demonstrated that most βb transmembrane proteins seem to be TonB-dependent receptors associated with transportation. Other proteins identified included, e.g., TolC efflux pump proteins, a BamA-like OM component of the βb transmembrane protein assembly machinery, and the LptD-like LPS assembly protein. The structural mapping of the immunodominant epitopes identified the location of conserved, surface-exposed, immunogenic regions for each vaccine candidate. The proteins identified in this study are currently being evaluated for experimental evidence for their involvement in virulence, disease pathogenesis, and physiology, in addition to vaccine development.Entities:
Keywords: Leptospira interrogans; bioinformatics; diderm bacteria; epitope prediction; genome mining; outer membrane protein; structural modeling; transport proteins
Year: 2017 PMID: 28496441 PMCID: PMC5406399 DOI: 10.3389/fimmu.2017.00463
Source DB: PubMed Journal: Front Immunol ISSN: 1664-3224 Impact factor: 7.561
Figure 1Reverse vaccinology (RV)- and structural vaccinology (SV)-based bioinformatics workflow for the identification of leptospiral vaccine candidates. The complete LIC genome-derived proteome provided the input sequences for 16 bioinformatics programs for the prediction of βb-outer membrane proteins (OMPs) and outer membrane (OM) lipoproteins. The number of proteins selected by each program is shown in parentheses. High confidence predicted proteins were screened using a Python algorithm. Proteins conserved among pathogenic Leptospira spp. and with no similarity to host proteins were selected for the three-dimensional (3D) structure prediction by fold recognition modeling. Functional annotation was based on the primary structure and on the 3D models. Strong binder major histocompatibility complex-II immunogenic epitopes were predicted for the selected proteins and a structural approach was employed to map the surface-related immunogenic regions in the βb-OMPs. The final list of conserved βb-OMPs and OM lipoproteins and the surface-related epitopes are novel prospective leptospiral vaccine candidates.
Functional annotation of βb-outer membrane proteins (OMPs) and outer membrane (OM) lipoproteins.
| Gene ID | Product/original annotation | Uniprot protein name | KEGG orthologs | Interpro scan analysis | |
|---|---|---|---|---|---|
| βb-OMPs | LIC10496 | Conserved hypothetical protein | Uncharacterized protein | TolC-like OMP | OM efflux protein |
| LIC10714 | OM receptor protein | OM receptor protein ( | OM receptor for Fe3+-dicitrate/TonB-dependent receptor (TBDR) | TBDR | |
| LIC10881 | OMP, TonB dependent | OMP, TonB dependent | TBDR | TBDR [plug and β-barrel (βb) domains | |
| LIC10896 | TonB-dependent outer membrane receptor | TonB-dependent outer membrane receptor ( | TonB-dependent outer membrane receptor | TBDR | |
| LIC10964 | TonB-dependent outer membrane hemin receptor | TonB-dependent outer membrane hemin receptor ( | TonB-dependent outer membrane hemin receptor | TBDR | |
| LIC11086 | Conserved hypothetical protein | Uncharacterized protein | Hypothetical protein | MetA-pathway of phenol degradation, putative | |
| LIC11211 | Hypothetical protein | Uncharacterized protein | Hypothetical protein | None predicted | |
| LIC11268 | Conserved hypothetical protein | Uncharacterized protein | Hypothetical protein | Alginate export domain | |
| LIC11458 | OMP, porin superfamily | OMP, porin superfamily (outer membrane LPS export porin—lps-ep—family | Hypothetical protein | None predicted | |
| LIC11506 | OMP | OMP | Hypothetical protein | Predicted OMP, Leptospiraceae | |
| LIC11623 | OMP | OMP | Hypothetical protein, Oma87-like OMP, BamA | Bacterial surface antigen (D15)/surface antigen variable number | |
| LIC12254 | OMP | OMP | Hypothetical protein, Oma87-related protein, surface antigen (D15) | Bacterial surface antigen (D15) | |
| LIC12374 | OMP, TonB dependent | OMP, TonB dependent ( | TonB-dependent outer membrane receptor, obalamin receptor protein | TBDR, βb, plug domain | |
| LIC12575 | Cytoplasmic membrane protein | Cytoplasmic membrane protein | Cytoplasmic membrane protein, TolC-like protein | Outer membrane efflux protein | |
| LIC13477 | Conserved hypothetical protein | Uncharacterized protein | Hypothetical protein | None predicted | |
| LIC20019 | Conserved hypothetical protein | Uncharacterized protein | Hypothetical protein | Putative porin/Porin 6 | |
| LIC20087 | OMP | OMP | Putative OMP, hypothetical protein | None predicted | |
| LIC20151 | TonB-dependent outer membrane receptor | TonB-dependent outer membrane receptor | TonB-dependent hemin-binding protein | TBDR, plug and βb domains | |
| OM lipoproteins | LIC10024 | Adenylate/guanylate cyclase (AGC) | AGC | AGC | 7TM-DISM receptor, extracellular domain, type 1; nucleotide cyclase; adenylyl cyclase class-3/4/guanylyl cyclase |
| LIC10647 | Conserved hypothetical protein | Uncharacterized protein | Hypothetical protein | None predicted | |
| LIC10713 | Putative lipoprotein | Putative lipoprotein | Putative lipoprotein, peptidase M75 | None predicted | |
| LIC11003 | LipL71 | LipL71 | LipL71, peptidoglycan-binding protein LysM | Domain of unknown function DUF4398; LysM domain | |
| LIC11755 | Conserved hypothetical protein | Uncharacterized protein | Hypothetical protein | None predicted | |
| LIC12048 | Conserved hypothetical protein | Uncharacterized protein | Hypothetical protein | None predicted | |
| LIC13411 | Putative lipoprotein | Putative lipoprotein | Hypothetical proteins | None predicted | |
| LIC20172 | Lipoprotein | Lipoprotein | Hypothetical proteins | LruC domain; domain of unknown function DUF4842 | |
.
.
.
Conservation of the 18 βb-outer membrane proteins (OMPs) and 9 outer membrane (OM) lipoproteins in 20 .
| Gene ID | Pathogenic | Intermediate | Saprophytic | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| βb-OMPs | LIC10496 | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | – | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| LIC10714 | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | |
| LIC10881* | ✓ | ✓ | ✓ | ✓ | – | ✓ | ✓ | ✓ | ✓ | – | – | – | – | – | – | – | – | – | – | – | |
| LIC10896* | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | – | – | – | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | |
| LIC10964 | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | – | – | – | ✓ | – | – | |
| LIC11086 | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | |
| LIC11211 | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | – | – | ✓ | ✓ | ✓ | – | – | – | |
| LIC11268 | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | |
| LIC11458 | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | |
| LIC11506 | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | – | – | ✓ | ✓ | ✓ | – | ✓ | ✓ | ✓ | ✓ | ✓ | |
| LIC11623 | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | |
| LIC12254 | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | – | ✓ | – | – | – | ✓ | |
| LIC12374 | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | |
| LIC12575 | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | |
| LIC13477 | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | |
| LIC20019 | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | |
| LIC20087 | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | |
| LIC20151 | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | – | – | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | |
| OM lipoproteins | LIC10024 | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | – | – | – | – | – | – |
| LIC10647 | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | – | – | – | ✓ | ✓ | – | – | – | – | – | – | |
| LIC10713 | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | – | ✓ | ✓ | ✓ | ✓ | – | |
| LIC11003 | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | |
| LIC11755 | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | |
| LIC12048 | ✓ | ✓ | – | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | – | – | – | ✓ | ✓ | ✓ | – | – | – | – | – | |
| LIC12690 | – | – | – | ✓ | – | – | ✓ | – | – | – | – | – | ✓ | – | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | |
| LIC13411 | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | |
| LIC20172 | ✓ | ✓ | ✓ | – | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | – | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | |
The search for leptospiral orthologs was repeated using LIC10881* and LIC10896*.
✓, conserved ortholog; −, no ortholog; ale., L. alexanderi; als., L. alstonii; bor., L. borgpetersenii; kir., L. kirschneri; kme., L. kmetyi; may., L. mayottensis; nog., L. noguchii; san., L. santarosai; wei., L. weilii; bro., L. broomii; fai., L. fainei; ina., L. inadai; lic., L. licerasiae; wolf., L. wolffii; bif., L. biflexa; mey., L. meyeri; ter., L. terpstrae; van., L. vanthielii; wolb., L. wolbachii; yan., L. yanagawae.
Figure 2Three-dimensional (3D) structures of the βb-outer membrane proteins (OMPs) and mapping of the immunogenic surface-related epitopes (SRE). Structural modeling was performed using I-TASSER, and the structures were visualized and the images generated using PyMOL. Proteins are orientated as following: the upper portion is surface-exposed on the OM and the lower portion is located in the periplasmic space. The orientation was derived from an interpretation of the orientation and structure of the matching PDB structure. Immunogenic major histocompatibility complex-II epitopes (strong binders) for 14 HLAs were predicted using NetMHCII and mapped onto the βb-OMPs structural models. Immunogenic SRE are indicated in purple in each βb-OMP structure.
Figure 3The Gene Ontology (GO) terms predicted by COFACTOR were based on the structural models of the βb-outer membrane proteins (OMPs) and outer membrane (OM) lipoproteins. The GO terms were assigned for three domains: molecular function, biological process, and cell localization. COFACTOR usually predicted more than one term for each GO domain for the target protein structure. The GO terms were collapsed to the closest parent term (based on the AmiGO2 database) to facilitate the overall view of the GO terms. In some cases, related terms were maintained for convenience, as indicated: 1—transport is also a child term of establishment of localization; 2—establishment of localization is also a child term of localization; 3—outer membrane is also a child term of membrane; 4—transferase activity and hydrolase activity are also children terms of catalytic activity; 5—ion binding and nucleotide binding are also children terms of binding; 6—cellular metabolic process is also a child term of metabolic process and cellular process; and 7—protein metabolic process is also a child term of metabolic process.
Closest PDB structure and quality assessment for the βb-outer membrane proteins (OMPs) and outer membrane (OM) lipoproteins models.
| Gene ID | Closest structure on PDB (PDB code), organism of origin | Quality assessment | ||||||
|---|---|---|---|---|---|---|---|---|
| TM-score | RMSD | Ramachandran disallowed residues (%) | ModFold score | Confidence and | QMEAN score | |||
| βb-OMPs | LIC10496 | OMP TolC (1tqq), | 0.862 | 1.10 | 0.7 | 0.5390 | HIGH: 3.324E−3 | 0.403 |
| LIC10714 | TonB-dependent receptor (TBDR)—ferrichrome-iron receptor FhuA (1fI1), | 0.840 | 1.10 | 8.3 | 0.6236 | HIGH: 1.38E−3 | 0.327 | |
| LIC10881* | TBDR—transferrin-binding protein A TbpA (3v89), | 0.592 | 4.86 | 3.4 | 0.3089 | MEDIUM: 3.63E−2 | 0.344 | |
| LIC10896* | TBDR—ferripyoverdine receptor FpvA (2w78), | 0.719 | 2.25 | 5.0 | 0.3127 | MEDIUM: 3.50E−2 | 0.197 | |
| LIC10964 | TBDR—Zn-transporter ZnuD (4rdr), | 0.837 | 1.37 | 6.3 | 0.5544 | HIGH: 2.834E−3 | 0.326 | |
| LIC11086 | Protein involved in meta-pathway of phenol degradation-like protein, Pput2725 (4rl8), | 0.769 | 1.31 | 2.3 | 0.2233 | LOW: 8.848E−2 | 0.231 | |
| LIC11211 | Toluene transporter TbuX (3bry), | 0.873 | 2.28 | 3.1 | 0.0000 | POOR: 9.017E−1 | 0.184 | |
| LIC11268 | TBDR—transferrin-binding protein A TbpA (3v89), | 0.914 | 1.65 | 4.2 | 0.0000 | POOR: 9.017E−1 | 0.137 | |
| LIC11458 | LPS assembly protein LptD (4q35), | 0.722 | 1.56 | 5.4 | 0.0777 | POOR: 4.02E−1 | 0.254 | |
| LIC11506 | OM Porin OmpG (2iww), | 0.660 | 3.33 | 3.1 | 0.1192 | POOR: 2.613E−1 | 0.083 | |
| LIC11623 | OMP assembly factor BamA (4k3b), | 0.506 | 3.37 | 4.9 | 0.2569 | LOW: 6.245E−2 | 0.349 | |
| LIC12254 | OMP assembly factor BamA lacking polypeptide translocation-associated domains 1–3 (4k3c), | 0.882 | 2.29 | 4.6 | 0.2076 | POOR: 1.042E−1 | 0.177 | |
| LIC12374 | TBDR—vitamin B12 transporter BtuB (2gsk), | 0.824 | 2.11 | 6.4 | 0.6066 | HIGH: 1.646E−3 | 0.282 | |
| LIC12575 | OMP TolC (1tqq), | 0.849 | 1.01 | 1.8 | 0.5207 | HIGH: 4.02E−3 | 0.403 | |
| LIC13477 | Alginate production protein AlgE (3rbh), | 0.804 | 1.81 | 3.3 | 0.2664 | LOW: 5.653E−2 | 0.259 | |
| LIC20019 | Plasminogen activator Pla/coagulase/fibrinolysin (2x4m), | 0.769 | 2.02 | 2.8 | 0.2117 | LOW: 9.987E−2 | 0.279 | |
| LIC20087 | Major Pilin Protein (4s3l), S | 0.896 | 2.20 | 3.7 | 0.0000 | POOR: 9.017E−1 | 0.246 | |
| LIC20151 | TBDR—vitamin B12 transporter BtuB (2gsk), | 0.794 | 1.57 | 11.6 | 0.5631 | HIGH: 2.588E−3 | 0.315 | |
| OM lipoproteins | LIC10024 | Adenylate cyclase type 10 (4clf), | 0.509 | 3.15 | 7.9 | 0.2229 | LOW: 8.883E−2 | 0.229 |
| LIC10647 | Major fimbrial subunit protein (4q98), | 0.828 | 2.89 | 3.0 | 0.0000 | POOR: 9.017E−1 | 0.21 | |
| LIC10713 | Putative iron-regulated protein A (4ecg), | 0.743 | 2.02 | 3.6 | 0.5401 | HIGH: 3.286E−3 | 0.438 | |
| LIC11003 | Cytoplasmic domain of bacterial cell division protein EzrA (4uxv), | 0.853 | 2.24 | 2.0 | 0.0226 | POOR: 7.126E−1 | 0.31 | |
| LIC11755 | RNA-dependent RNA polymerase (3ja4), Cypovirus 1 | 0.923 | 1.54 | 4.3 | 0.1582 | POOR: 1.741E−1 | 0.042 | |
| LIC12048 | Tc toxin/TcdB2/TccC3 (4o9x), | 0.890 | 2.48 | 4.5 | 0.0000 | POOR: 9.017E−1 | 0.144 | |
| LIC13411 | Chalcone-flavanone isomerase family protein (4doo), | 0.669 | 2.46 | 2.1 | 0.0000 | POOR: 9.017E−1 | 0.342 | |
| LIC20172 | Secretory component of immunoglobulin A (3chn), | 0.799 | 2.64 | 4.9 | 0.0000 | POOR: 9.017E−1 | 0.018 | |
.
.
Number of predicted strong binder (SB) major histocompatibility complex-II (MHC-II) epitopes in each βb-outer membrane protein (OMP) and outer membrane (OM) lipoproteins for 14 HLAs.
| Gene ID | Number of surface-related epitopes (SRE) identified among total SB epitopes—surface-related 9mer (SRE9)/SRE15 (SB9/SB15)c | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HLA-DRB 10101 | HLA-DRB 10301 | HLA-DRB 10401 | HLA-DRB 10404 | HLA-DRB 10405 | HLA-DRB 10701 | HLA-DRB 10802 | HLA-DRB 10901 | HLA-DRB 11101 | HLA-DRB 11302 | HLA-DRB 11501 | HLA-DRB 30101 | HLA-DRB 40101 | HLA-DRB 50101 | ||
| βb-OMPs | LIC10496 | 3/17 (29/111) | 0/0 (8/25) | 1/5 (4/16) | 0/0 (6/27) | 1/5 (4/23) | 0/0 (9/42) | 0/0 (0/0) | 1/3 (3/10) | 0/0 (10/39) | 2/12 (7/44) | 0/0 (3/10) | 1/5 (3/16) | 0/0 (15/50) | 0/0 (14/65) |
| LIC10714 | 14/60 (44/171) | 2/12 (5/23) | 8/28 (14/46) | 3/14 (11/39) | 7/21 (11/35) | 8/39 (21/74) | 1/3 (3/11) | 3/17 (7/30) | 1/1 (9/35) | 1/7 (5/30) | 3/8 (8/38) | 2/11 (6/35) | 2/22 (8/31) | 5/17 (19/68) | |
| LIC10881* | 23/56 (49/157) | 2/7 (8/20) | 2/6 (8/16) | 9/30 (16/57) | 10/25 (14/38) | 5/20 (20/97) | 0/0 (0/0) | 3/7 (6/15) | 8/22 (17/51) | 1/7 (8/38) | 5/14 (14/41) | 4/23 (8/44) | 5/14 (6/15) | 7/31 (18/89) | |
| LIC10896* | 23/73 (68/251) | 2/7 (9/33) | 7/19 (17/59) | 3/12 (10/37) | 6/21 (24/73) | 9/41 (30/132) | 3/4 (8/23) | 2/10 (12/53) | 7/29 (28/94) | 1/7 (6/34) | 1/2 (14/54) | 2/10 (6/29) | 2/4 (8/21) | 5/23 (27/94) | |
| LIC10964 | 9/33 (50/182) | 2/7 (4/12) | 3/8 (10/34) | 0/0 (6/32) | 5/21 (15/53) | 6/35 (26/111) | 0/0 (0/0) | 4/10 (7/22) | 1/4 (21/51) | 2/13 (6/37) | 2/5 (10/32) | 0/0 (2/7) | 1/3 (11/34) | 5/28 (19/88) | |
| LIC11086 | 2/9 (26/79) | 0/0 (1/4) | 1/5 (3/14) | 1/6 (2/7) | 1/5 (4/13) | 2/6 (11/41) | 1/6 (1/6) | 0/0 (9/26) | 2/11 (9/36) | 0/0 (6/26) | 0/0 (7/33) | 1/7 (1/7) | 0/0 (1/6) | 1/3 (11/43) | |
| LIC11211 | 5/13 (21/57) | 1/3 (3/10) | 0/0 (9/27) | 1/6 (6/24) | 1/2 (5/19) | 1/4 (12/40) | 0/0 (0/0) | 0/0 (1/3) | 1/2 (11/35) | 0/0 (3/11) | 1/5 (5/22) | 0/0 (1/5) | 0/0 (5/14) | 0/0 (9/40) | |
| LIC11268 | 9/44 (26/105) | 2/10 (4/14) | 2/6 (6/24) | 1/1 (7/23) | 3/9 (13/42) | 4/18 (10/42) | 0/0 (0/0) | 0/0 (0/0) | 3/10 (6/19) | 1/1 (4/13) | 0/0 (5/17) | 2/9 (9/37) | 1/3 (3/9) | 3/15 (6/25) | |
| LIC11458 | 16/56 (62/205) | 1/3 (11/38) | 7/30 (19/61) | 4/19 (19/76) | 7/26 (18/66) | 4/21 (25/100) | 0/0 (1/2) | 3/12 (7/23) | 6/23 (31/109) | 2/13 (8/42) | 2/9 (14/61) | 1/7 (5/30) | 1/7 (2/8) | 3/20 (28/134) | |
| LIC11506 | 7/28 (27/96) | 0/0 (0/0) | 2/7 (7/21) | 1/1 (4/12) | 2/5 (8/26) | 5/18 (20/78) | 0/0 (0/0) | 1/6 (6/19) | 4/20 (8/37) | 1/5 (2/12) | 4/20 (12/47) | 0/0 (4/18) | 0/0 (1/6) | 5/17 (12/36) | |
| LIC11623 | 16/65 (60/221) | 1/6 (11/43) | 4/16 (12/52) | 0/0 (8/25) | 2/9 (14/49) | 5/24 (29/123) | 0/0 (0/0) | 1/5 (5/20) | 6/16 (26/85) | 3/14 (7/30) | 1/1 (17/61) | 2/12 (9/48) | 5/18 (17/56) | 2/7 (27/102) | |
| LIC12254 | 4/27 (24/89) | 0/0 (3/15) | 0/0 (2/9) | 1/5 (8/42) | 0/0 (6/17) | 1/7 (10/48) | 1/2 (3/6) | 4/6 (9/18) | 2/7 (10/37) | 2/11 (8/30) | 0/0 (5/29) | 0/0 (8/25) | 0/0 (0/1) | 1/7 (11/56) | |
| LIC12347 | 12/40 (42/144) | 1/3 (7/29) | 2/11 (8/27) | 3/13 (8/37) | 2/7 (10/34) | 5/21 (17/80) | 0/0 (0/0) | 0/0 (2/7) | 2/7 (10/26) | 1/4 (2/10) | 1/7 (6/26) | 1/7(10/50) | 0/0 (0/0) | 2/6 (16/55) | |
| LIC12575 | 5/16 (32/98) | 0/0 (5/19) | 0/0 (1/6) | 0/0 (5/13) | 1/5 (5/27) | 2/12 (9/48) | 0/0 (0/0) | 0/0 (3/9) | 0/0 (9/31) | 1/2 (5/21) | 0/0 (4/14) | 0/0 (3/14) | 0/0 (7/25) | 2/8 (11/46) | |
| LIC13477 | 9/27 (32/112) | 0/0 (1/7) | 1/2 (7/31) | 0/0 (5/9) | 1/5 (9/31) | 1/12 (12/49) | 0/0 (0/0) | 2/8 (3/12) | 2/3 (7/21) | 1/2 (2/5) | 2/4 (9/33) | 1/5 (4/17) | 0/0 (1/2) | 2/11 (10/41) | |
| LIC20019 | 7/24 (21/70) | 1/6 (1/6) | 2/7 (5/16) | 3/13 (4/19) | 9/32 (10/38) | 4/24 (13/50) | 0/0 (0/0) | 1/7 (1/7) | 5/10 (11/33) | 0/0 (2/2) | 2/8 (7/19) | 3/14 (5/21) | 2/9 (3/15) | 1/7 (8/27) | |
| LIC20087 | −/− (17/94) | −/− (1/5) | −/− (4/15) | −/− (4/17) | −/− (11/32) | −/− (12/52) | −/− (1/7) | −/− (4/16) | −/− (7/22) | −/− (1/5) | −/− (4/17) | −/− (2/8) | −/− (1/6) | −/− (7/31) | |
| LIC20151 | 14/62 (44/157) | 3/9 (5/16) | 5/20 (10/35) | 4/17 (7/24) | 5/17 (15/43) | 4/22 (24/109) | 0/0 (0/0) | 1/2 (5/16) | 2/8 (10/36) | 4/20 (9/43) | 4/12 (12/43) | 1/2 (5/27) | 4/12 (8/21) | 5/25 (15/66) | |
| OM lipoproteins | LIC10024 | 54/223 | 10/31 | 9/37 | 16/74 | 21/58 | 39/135 | 3/8 | 8/25 | 36/112 | 6/24 | 32/103 | 6/25 | 13/35 | 30/144 |
| LIC10647 | 24/88 | 0/0 | 10/31 | 6/27 | 10/39 | 14/57 | 0/0 | 1/5 | 8/24 | 1/5 | 10/30 | 2/9 | 1/1 | 15/74 | |
| LIC10713 | 23/86 | 0/0 | 7/22 | 6/23 | 4/12 | 8/35 | 0/0 | 2/5 | 3/12 | 3/11 | 1/2 | 2/9 | 2/8 | 9/30 | |
| LIC11003 | 12/36 | 1/2 | 0/0 | 0/0 | 1/3 | 4/18 | 0/0 | 0/0 | 4/16 | 3/12 | 0/0 | 1/1 | 5/17 | 8/21 | |
| LIC11755 | 64/222 | 13/44 | 17/65 | 16/62 | 12/50 | 34/145 | 1/3 | 5/15 | 19/60 | 12/67 | 16/59 | 9/38 | 10/32 | 23/123 | |
| LIC12048 | 102/331 | 13/54 | 20/75 | 23/85 | 27/85 | 38/142 | 3/4 | 8/31 | 18/61 | 18/69 | 15/62 | 10/54 | 8/28 | 19/77 | |
| LIC13411 | 17/60 | 0/0 | 3/8 | 3/8 | 7/19 | 6/18 | 0/0 | 2/4 | 1/2 | 0/0 | 3/16 | 0/0 | 2/12 | 4/25 | |
| LIC20172 | 22/101 | 3/9 | 7/26 | 10/31 | 4/16 | 10/32 | 0/0 | 1/2 | 8/30 | 8/30 | 1/1 | 3/12 | 3/8 | 7/32 | |
.
.
.
Figure 4Sequence logos showing the frequency of amino acid residues at each position of the immunogenic surface-related epitopes (SREs) identified in the βb-outer membrane proteins (OMPs), according to multiple sequence alignment of the orthologs from pathogenic . Only the most conserved SRE from each βb-OMPs is shown. The overall height of the stack indicates the level of sequence conservation at that position, while the height of symbols within the stack indicates the relative frequency of each amino at that position.